Sonendo® Supports The Advancement Of Endodontics With A $50,000 Pledge To The AAE Foundation

Reinforces Its Commitment to Improve Clinical Quality, Economics of Root Canal Therapy

Oct 07, 2013, 10:00 ET from Sonendo, Inc.

LAGUNA HILLS, Calif., Oct. 7, 2013 /PRNewswire/ -- Sonendo®, the developer of a revolutionary technology for the endodontic marketplace, announced today its pledge of $50,000 to the American Association of Endodontists (AAE) Foundation for the advancement of endodontic education and research in the oral health care community.  The donation will help to fund educational grants for future endodontists, as well as research projects that generate new clinical data.

Keith V. Krell, President for the American Association of Endodontists Foundation, stated, "I want to personally thank Sonendo for its commitment and pledge of $50,000 to the American Association of Endodontists Foundation.  Like Sonendo, we are committed to inspiring research that will generate new knowledge, supporting endodontic education and improving the endodontic health of the public.  Your generous support will help us meet our mutual goals over the next several years." 

About the American Association of Endodontists

The American Association of Endodontists, headquartered in Chicago, Ill., represents more than 7,500 members worldwide. Endodontics is one of nine dental specialties formally recognized by the American Dental Association. The AAE, founded in 1943, is dedicated to excellence in the art and science of endodontics and to the highest standard of patient care. The Association inspires its members to pursue professional advancement and personal fulfillment through education, research, advocacy, leadership, communication and service. For more information about the AAE, visit the Association's website at

About Sonendo®
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform traditional endodontic therapy.  In the United States alone, more than 15 million root canal procedures are performed each year.  With its 510(k) FDA clearance and the commercialization of its Multisonic Ultracleaning System™ set to launch in 2014, Sonendo aims to improve clinical quality and business economics of current root canal therapy.  Sonendo investors include OrbiMed Advisors LLC, Themes Investment Partners, Fjord Ventures, and NeoMed Management.  For more information please visit:

Forward-Looking Statements
This announcement contains forward-looking statements that are based on management's beliefs, assumptions and expectations and on information currently available to management.  All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made.  However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made.  Sonendo does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.  Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.

Company Contact: 


Matt Clawson 

Len Hall

Allen & Caron Inc 

Allen & Caron Inc

(949) 474-4300 

(949) 474-4300

SOURCE Sonendo, Inc.